Financials
- Market Capitalization 2.11 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
30.4
ratio cours/chiffre d'affaires
8.76
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.68 USD | -4.00% | -7.34% | +6.28% | +129.89% | 2.14 B USD | ||
| 1967 | VCEL Vericel Corporation - Common Stock | 41.32 USD | +0.34% | -3.23% | -11.31% | +13.67% | 2.12 B USD | ||
| 1989 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.58 USD | -3.19% | -0.66% | -2.62% | +19.35% | 2.06 B USD | ||
| 1990 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.82 USD | -2.36% | -1.73% | +8.12% | +59.10% | 2.05 B USD |